메뉴 건너뛰기
International Journal of Obstetric Anesthesia
Volumn 16, Issue 3, 2007, Pages 299-300
Guidelines for use of recombinant factor VIIa in life-threatening post-partum haemorrhage
Author keywords

[No Author keywords available]
Indexed keywords

FIBRINOGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;
EID: 34249993135     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2007.02.008     Document Type: Letter
Times cited : (6)
References (9)
  • 1
    • 33845458346 scopus 로고    scopus 로고
    • Recombinant factor VIIa in massive postpartum haemorrhage
    • Karalapillai D., and Popham P. Recombinant factor VIIa in massive postpartum haemorrhage. Int J Obstet Anesth 16 (2007) 29-34
    • (2007) Int J Obstet Anesth , vol.16 , pp. 29-34
    • Karalapillai, D.1    Popham, P.2
  • 2
    • 33845427567 scopus 로고    scopus 로고
    • Use of recombinant activated factor VII in massive obstetric haemorrhage
    • Haynes J., Laffan M., and Platt F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth 16 (2007) 40-49
    • (2007) Int J Obstet Anesth , vol.16 , pp. 40-49
    • Haynes, J.1    Laffan, M.2    Platt, F.3
  • 3
    • 34247551016 scopus 로고    scopus 로고
    • Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective
    • Vincent J.L., Rossaint R., Riou B., Ozier Y., Zideman D., and Spahn D.R. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective. Crit Care 10 (2006) R120
    • (2006) Crit Care , vol.10
    • Vincent, J.L.1    Rossaint, R.2    Riou, B.3    Ozier, Y.4    Zideman, D.5    Spahn, D.R.6
  • 4
    • 0024540990 scopus 로고
    • Rules of evidence and clinical recommendations on the use of antithrombotic agents
    • Sackett D.L. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95 (1989) 2S-4S
    • (1989) Chest , vol.95
    • Sackett, D.L.1
  • 5
    • 18144424405 scopus 로고    scopus 로고
    • Recombinant factor VIIa for life-threatening post-partum haemorrhage
    • Ahonen J., and Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 94 (2005) 592-595
    • (2005) Br J Anaesth , vol.94 , pp. 592-595
    • Ahonen, J.1    Jokela, R.2
  • 6
    • 24644491444 scopus 로고    scopus 로고
    • Recombinant factor VIIa as adjunctive therapy for bleeding control in severly injured trauma patients. Two parallel randomized, placebo-controlled, double-blind clinical trials
    • Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severly injured trauma patients. Two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-15
    • (2005) J Trauma , vol.59 , pp. 8-15
    • Boffard, K.D.1    Riou, B.2    Warren, B.3
  • 7
    • 3242775982 scopus 로고    scopus 로고
    • Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
    • Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 32 (2004) 858-873
    • (2004) Crit Care Med. , vol.32 , pp. 858-873
    • Dellinger, R.P.1    Carlet, J.M.2    Masur, H.3
  • 8
    • 33750066637 scopus 로고    scopus 로고
    • Surviving Sepsis - Practice Guidelines, Marketing Campaigns, and Eli Lilly
    • Eichacker P.Q., Natanson C., and Danner R.L. Surviving Sepsis - Practice Guidelines, Marketing Campaigns, and Eli Lilly. N Engl J Med 355 (2006) 1640-1642
    • (2006) N Engl J Med , vol.355 , pp. 1640-1642
    • Eichacker, P.Q.1    Natanson, C.2    Danner, R.L.3
  • 9
    • 0036032289 scopus 로고    scopus 로고
    • Ongoing NovoSeven trials
    • Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med 28 Suppl 2 (2002) S248-S255
    • (2002) Intensive Care Med , vol.28 , Issue.SUPPL. 2
    • Erhardtsen, E.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.